Skip to main content
logo
Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
7.37
-0.03 (-0.41%)
Aug 12, 2026, 2:18 PM EDT - Market open

Abeona Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
14.545.82-3.51.413
Revenue Growth
---147.53%-52.87%-70.00%
Gross Profit
8.422.4-1.90.963
Operating Income
-92.75-89.45-64.21-47.14-50.92-89.84
Net Income
-22.2471.18-63.73-54.19-43.48-84.94
Earnings Per Share
0.971.01-1.55-2.53-5.53-21.57
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
168.27191.497.7252.2352.1545.02
Total Debt
23.1724.9723.055.47.639.38
Net Cash (Debt)
145.1166.4474.6746.8344.5235.65
Net Cash Growth
141.11%122.89%59.47%5.17%24.90%-58.70%
Net Cash Per Share
2.372.521.822.195.669.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-77.73-76.33-56.02-37.01-43.48-65.67
Capital Expenditures
-7.51-7.98-2.45-0.33-0.13-4.15
Free Cash Flow
-85.24-84.3-58.46-37.34-43.61-69.82
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
57.90%41.15%-54.14%68.18%100.00%
Operating Margin
-637.92%-1536.91%--1346.71%-3600.78%-2994.53%
Pretax Margin
457.06%1224.79%--1548.23%-2807.36%-2831.20%
Profit Margin
-152.93%1223.08%--1548.23%-2807.36%-2831.20%
FCF Margin
-586.22%-1448.47%--1066.86%-3084.37%-2327.20%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
8.105.22----
Forward PE
-231.80----
PS Ratio
29.0149.84-37.9738.6016.68